Ellevest Inc’s Asensus Surgical, Inc. ASXC Stock Holding History

Ellevest Inc’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-706	Closed	–	–	1376
2020 Q1	$0	Buy	+706	New	+$737	﹤0.01%	1338

Other funds holding ASXC

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Ellevest Inc's ASXC Position: Q2 2020 in Review

Ellevest Inc sold out of Asensus Surgical, Inc. (ASXC) in Q2 2020, closing a stake of 706 shares.

Ellevest Inc first reported a position in ASXC in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 72 funds tracked by Wall St. Rank hold ASXC as of Q2 2020.

Ellevest Inc reported no remaining Asensus Surgical, Inc. position as of Q2 2020 after selling out during the quarter.
Ellevest Inc sold 706 Asensus Surgical, Inc. shares in Q2 2020.
Ellevest Inc first reported a position in Asensus Surgical, Inc. in Q1 2020 and held it in 1 quarter.
Ellevest Inc's Asensus Surgical, Inc. position peaked at $0 in Q1 2020.
72 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2020.

Based on Ellevest Inc's 13F filing for Q2 2020, filed 6 Jul 2020.